盐酸曲普利啶与醋酸甲萘氢醌联合治疗慢性荨麻疹95例疗效观察  

Triprolidine Hydrochloride and Menadiol Acetate Combined with the Treatment of Chronic Urticaria Clinical Observation of 95 Cases

作　　者：郭新明[1] GUO Xin-ming(Heze Municipal Hospital, Heze 274000, Chin)

机构地区：[1]山东菏泽市立医院,山东菏泽274000

出　　处：《中国医药指南》2017年第19期20-21,共2页Guide of China Medicine

摘　　要：目的观察和分析盐酸曲普利啶与醋酸甲萘氢醌联合治疗慢性荨麻疹95例疗效。方法选择本院在2013年10月至2016年11月收治的95例慢性荨麻疹患者为研究主体。分成A组和B组,分别是48例和47例。A组给予盐酸曲普利啶与醋酸甲萘氢醌联合治疗,B组给予盐酸曲普利啶单纯治疗。对比临床疗效和不良反应情况。结果 A组的治疗总有效率是95.83%,B组的治疗总有效率是82.98%,对比差异明显,有统计学意义(P<0.05)。A组的不良反应率是16.67%,B组的不良反应发生率是19.15%,对比无差异,无统计学意义(P>0.05)。结论为慢性荨麻疹患者采取盐酸曲普利啶与醋酸甲萘氢醌联合治疗具有较佳的临床疗效,且不良反应轻微,值得推广。Objective To observe and analyze the curative effect of 95 cases of triprolidine hydrochloride combined with menadiol acetate for the treatment of chronic urticaria. Methods 95 cases of chronic urticaria patients admitted to our hospital in October 2013-November 2016 year as the research subject. Divided into A group and B group were 48 cases and 47 cases of. A group were given tramadol hydrochloride Plymouth and ceftazidime menadiol acetate combined therapy, B group received triprolidine hydrochloride treatment alone. The clinical efficacy and adverse reactions compared. Results The treatment group A total effective rate is 95.83%, the treatment group B total effective rate was 82.98%, the difference was significant, with statistical significance（P〈0.05） adverse reaction of. A group the rate is 16.67%, the adverse reaction rate of B group was 19.15%, no difference, no statistical significance（P〈0.05）. Conclusion The use of triprolidine hydrochloride and menadiol acetate combined therapy is better for patients with chronic urticaria Clinical efficacy, and adverse reactions, is worthy of promotion.

关 键 词：盐酸曲普利啶 醋酸甲萘氢醌 慢性荨麻疹 临床疗效 

分 类 号：R758.24[医药卫生—皮肤病学与性病学]